Exero Medical s Smart Sensor Granted FDA Breakthrough Designation
USA - English
News provided by
Share this article
Share this article
OR YEHUDA, ISRAEL, Dec. 15, 2020 /PRNewswire/ Exero Medical, developer of a wireless system for early detection of anastomotic leaks (AL) following gastrointestinal (GI) surgery, today announced that it has been granted FDA Breakthrough Designation – a status reserved for medical devices that provide more effective treatment or diagnosis of potentially life-threatening or irreversible conditions or diseases.
To achieve this status, Exero Medical demonstrated that its smart sensor for the early detection of potentially lethal AL following GI surgery, represents a breakthrough that may demonstrate substantial improvement over any available solution.